Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5798 | 1573 | 42.3 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
518 | 3 | ANGIOGENESIS//RETINOPATHY OF PREMATURITY//ENDOSTATIN | 20826 |
361 | 2 | ANGIOGENESIS//ENDOSTATIN//VEGF | 17372 |
5798 | 1 | ENDOSTATIN//ANGIOSTATIN//COLLAGEN XVIII | 1573 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ENDOSTATIN | authKW | 4078279 | 23% | 57% | 367 |
2 | ANGIOSTATIN | authKW | 1232438 | 8% | 50% | 127 |
3 | COLLAGEN XVIII | authKW | 702892 | 3% | 77% | 47 |
4 | RECOMBINANT HUMAN ENDOSTATIN | authKW | 475536 | 2% | 70% | 35 |
5 | TUMSTATIN | authKW | 466323 | 2% | 78% | 31 |
6 | ENDOSTAR | authKW | 400376 | 2% | 54% | 38 |
7 | KNOBLOCH SYNDROME | authKW | 211352 | 1% | 78% | 14 |
8 | PLASMINOGEN KRINGLE 5 | authKW | 176457 | 1% | 91% | 10 |
9 | CANSTATIN | authKW | 164411 | 1% | 71% | 12 |
10 | COLLAGEN XV | authKW | 138028 | 1% | 89% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 5910 | 33% | 0% | 512 |
2 | Medicine, Research & Experimental | 1433 | 12% | 0% | 192 |
3 | Biochemistry & Molecular Biology | 1074 | 25% | 0% | 392 |
4 | Biotechnology & Applied Microbiology | 579 | 9% | 0% | 149 |
5 | Cell Biology | 570 | 12% | 0% | 182 |
6 | Genetics & Heredity | 272 | 7% | 0% | 108 |
7 | Biophysics | 237 | 6% | 0% | 87 |
8 | Ophthalmology | 138 | 3% | 0% | 50 |
9 | Gastroenterology & Hepatology | 106 | 3% | 0% | 52 |
10 | Peripheral Vascular Diseases | 106 | 3% | 0% | 50 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AGEN UNIT | 104230 | 2% | 15% | 35 |
2 | CELL SIGNALING TUMOR ANGIOGENESIS | 99824 | 0% | 86% | 6 |
3 | BEIJING PROT THER EUT | 60728 | 1% | 24% | 13 |
4 | ENGN ANTITUMOR PROT THER EUT | 51065 | 1% | 26% | 10 |
5 | NANJING STAMOTOL HOSP | 43672 | 0% | 75% | 3 |
6 | CELL SIGNALING ANGIOGENESIS | 25879 | 0% | 67% | 2 |
7 | JIANGSU ENGN CANC BIOTHER Y | 25879 | 0% | 67% | 2 |
8 | TUMOR TARGETING GRP | 25875 | 0% | 33% | 4 |
9 | CNRS UP A 6021 | 24953 | 0% | 43% | 3 |
10 | OULU CELL MATRIX | 23605 | 1% | 9% | 14 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER GENE THERAPY | 7181 | 2% | 1% | 27 |
2 | MATRIX BIOLOGY | 3225 | 1% | 1% | 15 |
3 | CANCER RESEARCH | 2273 | 4% | 0% | 69 |
4 | GENE THERAPY | 1575 | 1% | 0% | 18 |
5 | PROTEIN EXPRESSION AND PURIFICATION | 1183 | 1% | 0% | 17 |
6 | NATO ADVANCED SCIENCE INSTITUTES SERIES, SERIES A, LIFE SCIENCES | 857 | 0% | 1% | 4 |
7 | ACTA BIOCHIMICA ET BIOPHYSICA SINICA | 840 | 1% | 0% | 11 |
8 | MOLECULAR THERAPY | 767 | 1% | 0% | 12 |
9 | INTERNATIONAL JOURNAL OF CANCER | 708 | 2% | 0% | 28 |
10 | HUMAN GENE THERAPY | 684 | 1% | 0% | 11 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ENDOSTATIN | 4078279 | 23% | 57% | 367 | Search ENDOSTATIN | Search ENDOSTATIN |
2 | ANGIOSTATIN | 1232438 | 8% | 50% | 127 | Search ANGIOSTATIN | Search ANGIOSTATIN |
3 | COLLAGEN XVIII | 702892 | 3% | 77% | 47 | Search COLLAGEN+XVIII | Search COLLAGEN+XVIII |
4 | RECOMBINANT HUMAN ENDOSTATIN | 475536 | 2% | 70% | 35 | Search RECOMBINANT+HUMAN+ENDOSTATIN | Search RECOMBINANT+HUMAN+ENDOSTATIN |
5 | TUMSTATIN | 466323 | 2% | 78% | 31 | Search TUMSTATIN | Search TUMSTATIN |
6 | ENDOSTAR | 400376 | 2% | 54% | 38 | Search ENDOSTAR | Search ENDOSTAR |
7 | KNOBLOCH SYNDROME | 211352 | 1% | 78% | 14 | Search KNOBLOCH+SYNDROME | Search KNOBLOCH+SYNDROME |
8 | PLASMINOGEN KRINGLE 5 | 176457 | 1% | 91% | 10 | Search PLASMINOGEN+KRINGLE+5 | Search PLASMINOGEN+KRINGLE+5 |
9 | CANSTATIN | 164411 | 1% | 71% | 12 | Search CANSTATIN | Search CANSTATIN |
10 | COLLAGEN XV | 138028 | 1% | 89% | 8 | Search COLLAGEN+XV | Search COLLAGEN+XV |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SEPPINEN, L , PIHLAJANIEMI, T , (2011) THE MULTIPLE FUNCTIONS OF COLLAGEN XVIII IN DEVELOPMENT AND DISEASE.MATRIX BIOLOGY. VOL. 30. ISSUE 2. P. 83-92 | 116 | 79% | 45 |
2 | FOLKMAN, J , (2006) ANTIANGIOGENESIS IN CANCER THERAPY - ENDOSTATIN AND ITS MECHANISMS OF ACTION.EXPERIMENTAL CELL RESEARCH. VOL. 312. ISSUE 5. P. 594-607 | 97 | 76% | 340 |
3 | WALIA, A , YANG, JF , HUANG, YH , ROSENBLATT, MI , CHANG, JH , AZAR, DT , (2015) ENDOSTATIN'S EMERGING ROLES IN ANGIOGENESIS, LYMPHANGIOGENESIS, DISEASE, AND CLINICAL APPLICATIONS.BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. VOL. 1850. ISSUE 12. P. 2422 -2438 | 143 | 59% | 2 |
4 | POLUZZI, C , IOZZO, RV , SCHAEFER, L , (2016) ENDOSTATIN AND ENDOREPELLIN: A COMMON ROUTE OF ACTION FOR SIMILAR ANGIOSTATIC CANCER AVENGERS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 97. ISSUE . P. 156 -173 | 129 | 47% | 4 |
5 | RICARD-BLUM, S , BALLUT, L , (2011) MATRICRYPTINS DERIVED FROM COLLAGENS AND PROTEOGLYCANS.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 16. ISSUE . P. 674 -697 | 137 | 56% | 30 |
6 | MONBOISSE, JC , OUDART, JB , RAMONT, L , BRASSART-PASCO, S , MAQUART, FX , (2014) MATRIKINES FROM BASEMENT MEMBRANE COLLAGENS: A NEW ANTI-CANCER STRATEGY.BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. VOL. 1840. ISSUE 8. P. 2589 -2598 | 79 | 65% | 17 |
7 | XU, FG , MA, QY , SHA, HC , (2007) OPTIMIZING DRUG DELIVERY FOR ENHANCING THERAPEUTIC EFFICACY OF RECOMBINANT HUMAN ENDOSTATIN IN CANCER TREATMENT.CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS. VOL. 24. ISSUE 5. P. 445 -492 | 95 | 70% | 15 |
8 | WICKSTROM, SA , ALITALO, K , KESKI-OJA, J , (2005) ENDOSTATIN SIGNALING AND REGULATION OF ENDOTHELIAL CELL-MATRIX INTERACTIONS.ADVANCES IN CANCER RESEARCH, VOL 94. VOL. 94. ISSUE . P. 197 -+ | 94 | 66% | 33 |
9 | RAMCHANDRAN, R , KARUMANCHI, SA , HANAI, J , ALPER, SL , SUKHATME, VP , (2002) CELLULAR ACTIONS AND SIGNALING BY ENDOSTATIN.CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION. VOL. 12. ISSUE 3. P. 175-191 | 85 | 75% | 13 |
10 | DIXELIUS, J , CROSS, MJ , MATSUMOTO, T , CLAESSON-WELSH, L , (2003) ENDOSTATIN ACTION AND INTRACELLULAR SIGNALING: BETA-CATENIN AS A POTENTIAL TARGET?.CANCER LETTERS. VOL. 196. ISSUE 1. P. 1-12 | 71 | 76% | 32 |
Classes with closest relation at Level 1 |